Revvity (RVTY) Set to Announce Earnings on Monday

Revvity (NYSE:RVTY - Get Free Report) is scheduled to be releasing its earnings data before the market opens on Monday, November 4th. Analysts expect Revvity to post earnings of $1.13 per share for the quarter. Persons interested in listening to the company's earnings conference call can do so using this link.

Revvity (NYSE:RVTY - Get Free Report) last posted its earnings results on Monday, July 29th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.12 by $0.10. The firm had revenue of $691.70 million for the quarter, compared to analysts' expectations of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. The business's revenue was down 2.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.21 earnings per share. On average, analysts expect Revvity to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Revvity Trading Up 1.0 %

Shares of Revvity stock traded up $1.16 during midday trading on Monday, reaching $117.49. 772,396 shares of the company's stock traded hands, compared to its average volume of 815,058. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.98 and a current ratio of 2.27. The company has a market cap of $14.50 billion, a PE ratio of 97.10, a price-to-earnings-growth ratio of 3.27 and a beta of 1.05. The stock has a 50 day moving average of $121.51 and a 200-day moving average of $113.55. Revvity has a 12 month low of $79.50 and a 12 month high of $128.15.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 7th. Investors of record on Friday, January 17th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, January 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.24%. Revvity's dividend payout ratio is presently 23.14%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on RVTY shares. Citigroup upped their target price on Revvity from $135.00 to $145.00 and gave the company a "buy" rating in a report on Tuesday, July 30th. Bank of America increased their price objective on Revvity from $118.00 to $127.00 and gave the stock a "neutral" rating in a report on Tuesday, July 30th. Leerink Partners increased their price objective on Revvity from $130.00 to $135.00 and gave the stock an "outperform" rating in a report on Thursday, October 17th. Barclays upgraded Revvity from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $125.00 to $140.00 in a report on Tuesday, October 15th. Finally, Leerink Partnrs upgraded Revvity to a "strong-buy" rating in a report on Monday, July 8th. Seven investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $127.20.

Insider Activity at Revvity

In related news, insider Joel S. Goldberg sold 3,500 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total transaction of $412,510.00. Following the sale, the insider now directly owns 33,400 shares of the company's stock, valued at $3,936,524. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Revvity news, insider Tajinder S. Vohra sold 2,153 shares of the firm's stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $122.09, for a total value of $262,859.77. Following the transaction, the insider now directly owns 23,960 shares of the company's stock, valued at approximately $2,925,276.40. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Joel S. Goldberg sold 3,500 shares of the firm's stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total value of $412,510.00. Following the completion of the transaction, the insider now directly owns 33,400 shares in the company, valued at $3,936,524. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 7,807 shares of company stock valued at $937,576 over the last ninety days. Insiders own 0.60% of the company's stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.